Every day, 2.5 quintillion bytes of data are created; 1/3 of that data is healthcare-related. Given the amount of information “noise” in the market, a new NPP landscape has emerged. HCPs now take initiative to source the information they need, when and where they want it (particularly in light of reduced rep access). Register Now!
Download this FREE infographic for comparative data and valuable insider insights that pharma companies should consider for their products and marketing strategies.
It has been and big year for gene therapy. This webinar will review Commissioner Gottlieb’s statement, provide an overview of the six guidance documents, and discuss the implications for development of new gene therapy products from the perspective of regulatory strategy, clinical development, pharmacology/toxicology considerations, and CMC development.
20% of biopharma companies we surveyed are digitally maturing. Leaders should think about digital differently -- move from simply doing digital to being digital. Here’s a North Star approach to take. Read the full article.
Using a holistic approach to selecting and testing primary packaging and delivery systems can help pharmaceutical manufacturers mitigate particulate risk. Join West experts to learn how a holistic approach to drug product packaging, testing and evaluation can help reduce risk and overcome challenges associated with particulate. Register now!
Clinical research and biobanking industries are rapidly adopting eConsent as an alternative to paper. Learn how eConsent can provide patients with clear and easy-to-understand clinical trial information, improve patient compliance, reduce inspection finding, and enable process efficiencies. Register now!
We develop enabling formulations for pre-clinical drugs - parenteral, topical, and oral dosage forms. Our expertise includes nano-particles, nano-emulsions, amorphous dispersions, and controlled-release. We provide analytical development and GMP manufacturing for Phase I studies.
Come visit us at AAPS booth #2814
This webinar will discuss several capsule formulations used in DPIs and will compare their performance, an overview on some of the novel methods being employed to evaluate the physical characteristics and mechanical properties of capsules, and the factors influencing the aerosolisation performance of different capsule types. Register now!
This webinar will examine the effect of technology advancements on the future responsibilities of clinical data managers and discusses the needs introduced by the application of new technologies and broader data source availability.
Learn how to use advanced tools and technologies, such as natural language processing, to identify macro and micro healthcare market trends in the US, detect patterns in clinical trial protocol deviations, and discern patterns in patient sentiment, compliance, routines, behaviors, and overall treatment satisfaction and outcomes.
This webinar will introduce a QSP model of targeted anabolic growth factors for intra-articular injection for the treatment of diseased joints that was used to systematically map out drug- and target-parameter space to:
- Identify tradeoffs between target and drug properties
- Maximize therapeutic window and tissue targeting
- Identify key missing data
Join us to hear Steve Gens, managing partner at Gens and Associates, provide real-world examples for each step and guidance on how to justify making these changes within your organization. This webinar will outline five actionable steps to help you establish roles and responsibilities, institute key processes, and improve long-term outcomes. Register Now!
Modernizing manufacturing equipment, processes, and infrastructure with the newest technology has become a focus to improve their efficiency and overall bottom line. Attend this webinar and learn how to utilize connected IoT devices and data analytics to optimize manufacturing processes, novel ways to use machine learning technology in the cloud, and more.
Join Cardinal Health experts in the second of our three-part webinar series, as we review the qualitative phase of PRO instrument development within the context of an individual drug development program, PRO instrument modification and regulatory requirements associated with development of these measures for specific populations. Register now!
This webinar will benefit executives at Biotech and Pharmaceutical companies interested in learning more about 505(b)(2), the pathway of choice. When executed properly, this regulatory pathway enables a lower cost, lower risk, and faster path to approval and market. Register Now!
Tying content to revenue and proving its ROI can be difficult. Join the webinar to learn why understanding content analytics is so important to medical device marketers, what metrics you should be tracking, and how sales enablement can help tie content to revenue. Register now!
With this report, discover what over 800 research professionals think about technology's impact on clinical trial operations and learn the necessary steps to see more value from your research systems. Click here to download.
Watch this webinar to hear from Bryan Knox on reliable approaches that have supported hundreds of small and virtual companies help build value to their lead candidates in early phases of development as well as help accelerate the development process to overcome formulation challenges. Register to watch on-demand.
Life sciences companies are embracing the essential roles that real world data (RWD) and the generation of real world evidence (RWE) play in the development of new treatments for patients.
This whitepaper will explore three areas where RWD and RWE are being applied to improve the design and execution of clinical studies. Download now to learn more.
Join this webinar to discover how ZipDose® by Aprecia enables a new world of powerful formulation solutions for NCE product candidates in Phase I or Phase II development and testing. You’ll also review how 3DP can offer formulation advantages such as better molecule protection, adjustable powder layers and flexibility in dose loading for adaptive clinical trials.
Several frameworks exist to assess the value of oncology treatments, each with its own set of criteria to determine ‘value’. Understand the value drivers for various stakeholders for oncology products, the use of value frameworks to optimize drug positioning, approval, and access, and how to compare your product’s value across frameworks. Watch now!
Discover key stats and valuable insights on how patient leaders and their online communities share information. How likely are they to ask their doctor about specific medication? What platforms are used when information is shared privately? Get the answers to these questions and more.
Understanding Commercialization Within Biopharma is an intensive two-day course focused on the major considerations integral to the successful launch/commercialization of a therapeutic and why it is important for everyone in the industry to better understand the process. Register today!
Results from one of the industry's largest, global clinical operations surveys shares how pharmas and CROs are evolving clinical trial processes. Download the report.
Manufacturing is one of the most challenging environments in the pharmaceutical industry. This whitepaper discusses how new data acquisition and analytic technologies can boost manufacturing intelligence and agility, how companies like Merck and Moderna optimize manufacturing operations utilizing the cloud, and more. Download it now!
Watch this on-demand webinar to find out how HealthPrize uses gamification, behavioral economics, education and rewards to improve patient adherence.
Learn how top pharmas and CROs plan to speed database build and data collection, as well as their top challenges and future priorities. This in-depth research from Tufts follows their industry-wide eClinical Landscape Study, examining the major cause of database build delays and their impact on trial cycle times. Register Now
Considering oncology drug development and clinical trial for Asia market? Join the experts from CMIC Group, the largest CRO in Japan, to learn the insights on how to start your early oncology drug development and ensure clinical trial success. Register now!
Find out how a pharmaceutical company can recognize both unfavorable drug substance properties and incompatibility between an API and its formulation to avoid potential risks to the patient as well as costly interruptions during development.
Examine the linguistic and cultural considerations of global eCOA and BYOD. Download now!
Read this whitepaper to learn more about two main areas where a drug developer can face significant obstacles during biologics development. By evaluating these capabilities, a drug developer can answer the critical question of whether its in-house strategy is ready for the uncertainties of drug development.
Collaborate in a digital world to improve patient outcomes. With SAP, you can leverage cutting-edge technology to improve focus on the patient and caregiver – while enhancing global health in new and innovative ways. Download our Whitepaper Here!
Learn what's unique about applying AI and machine learning in the life science industry and how to strike balance between automation and oversight. In this webinar, hear how AI can strengthen your brand strategy and optimize execution in the field. Get tips on where to begin and how to prepare.
Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more.
What can sales and marketing teams do to address the issue of compliance? Learn why compliance is so important to sales and marketing teams in the medical device industry, how digital transformation and sales enablement can help sales and marketing teams, and more. Register now!
Champions Oncology PDX models are the most highly-characterized, clinically-relevant cohorts of PDX models to optimally predict success and accelerate the drug development process. This webinar will provide an overview of the various unique and advanced translational tools that are offered by Champions oncology in an in vivo and ex vivo setting.
For pharma marketers, mobile is the place to be—literally. Attend this webinar and learn about going beyond location alone to leverage critical factors that affect healthcare decisions, important privacy and fraud guardrails required for successful mobile audience targeting, and more. Register now!
As a scientist or researcher, you need fast, cost-effective access to scientific content. This guide covers useful tips and tools to accelerate your literature search, simplify access to papers, and minimize acquisition costs—putting you on the fast track to scientific discovery. Download Now.
Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data at every stage of the data value chain.
One year ago, Thermo Fisher Scientific completed the acquisition of Patheon, creating the world’s most comprehensive and sophisticated end-to-end CDMO partner. But what does that mean to the industry today?
Navigating patient-reported outcomes (PROs) such as unobservable symptoms, treatment satisfaction, quality of life, and treatment adherence is a critical component of a patient centric healthcare system. Join our experts in the first of a three-part webinar series on PROs, as they provide insight on the foundational elements of PROs and recent regulatory trends. Register now!
This webinar will present a quantitative systems pharmacology case study which assesses a Lipid Nanoparticle to treat Crigler-Najjar Syndrome Type 1. Learn how the model was used to support translation from preclinical to clinical trials as well as first-in-human dosing.
The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry.
This eBook is a collection of Biotech Primer WEEKLYs from the past 12 months. The Biotech Primer WEEKLY is a one-page, easy-to-ready newsletter delivered each Thursday right to your inbox. If you are not already registered to receive the Biotech Primer WEEKLY register today here.
Life science companies are responding with Real World Evidence (RWE) programs to capture data from clinical through post-market activities from a variety of sources. Learn how the centralization of data assets enables organizational intelligence by equipping companies to understand the needs of patients and other stakeholders, and how their products can meet them. Download this Whitepaper!
This webinar will help you understand what is involved in an NDA including regulatory strategy, data integration and readiness, and electronic publishing, and provide tips that can help you avoid common pitfalls in the submissions process.
Download this FREE whitepaper for comparative data and valuable insider insights that pharma companies should consider for their products and marketing strategies.
Participate in this short, ten minute survey on data access and analytics in health plans today. Input from professionals in the field is important, and we appreciate your participation.
As the number of clinical trials increases so does the complexity and number of US and global sites needed to foster trial success. Read what was discovered after a survey on current site payment practices, how these practices are measured, what process improvement initiatives are currently being explored, what are some of the barriers to change, and what site payment trends will occur over the next five years. Download it now!
Develop a basic understanding of principles and concepts of bioavailability of oral drugs. This course, designed for scientists involved in pharmaceutical drug development, will simplify the concepts of bioavailability and how to manage biopharmaceutical challenges, and identify why it is an important factor in optimal therapies for patients. Enroll Now!
Download this infographic for comparative data and valuable insider insights on dermatology drug adherence that pharma companies should consider for their products and marketing strategies.
Take this quick 10 minute survey on the state of sales enablement in the healthcare industry. A $5 Amazon Gift Card will be sent to the first 50 qualified respondents. Complete the survey now!
Hear new results from one of the industry's largest, global clinical operations surveys, the Veeva 2018 Unified Clinical Operations Survey. The Veeva 2018 Unified Clinical Operations Survey examines the industry’s progress toward a unified clinical operating environment. Register Now
Learn why unifying clinical applications is an industrywide priority for clinical operations leaders. Read the report.
Research tells us that the role of patient-physician communication is a key factor that can impact adherence.
Download this Infographic to learn how Atlantis Healthcare uses health psychology to improve patient-physician communication and drive higher rates of treatment adherence.
Join Joe Lipari, Director - Global Traceability from Systech, as we map out a proven route to serialization success along with Steve Kane, Head of Product Integrity Program Global IT for Shire and Ann Schaefer, Director - Supply Chain Management at Acorda Therapeutics. The panel will discuss complexity of the regulations, hurdles they overcame, and solutions that carried them over the finish line. Register Now.
Researchers are encumbered with a plethora of disparate data and analytic tools. These assets pose several challenges which need to be overcome to ensure they satisfy their intended purpose.
Watch this webinar to learn how real-time, self-service access to longitudinal patient data is changing the way researchers evaluate treatment effectiveness, safety, protocol design, and more. Register now.
Expanding an existing portfolio with lifecycle management strategies does involve some expense, but it’s not nearly as expensive as developing an entirely new drug. Learn about some new areas of exploration, including novel drug combinations and more. Read the whitepaper to learn more.
“Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure.
Watch this webinar and discover what best practices sponsors and CROs should follow when evaluating a current or future investigator payments partner. Register here.
The new EU HTA Directive requires consistent comparative clinical efficacy assessment of EMA assessed treatments. Understand the history of the Directive, what is included, the proposed structure and timing, potential implications for industry and stakeholders, and how to prepare. Register now.
Download this infographic for comparative data and valuable insider insights on rheumatology drug adherence that pharma companies should consider for their products and marketing strategies.
Read a case study on how to utilize a parallel screening approach to selecting a most suitable formulation technology for an early phase BCS Class II compound. The molecule was advanced to animal study with enhanced bioavailability in 12 weeks.
Watch a video to learn how to incorporate everything you need to progress you drug candidate from late stage discovery to phase I into one comprehensive offering which can quickly help achieve your milestone
Study sponsors often focus on upfront planning to ensure clinical sites are prepared to reach study milestones but ignore the logical challenges of managing their clinical returns. Learn how developing a forward-thinking plan to manage clinical returns can reduce study close out risk.
Advancing beyond Phase I can be exciting – and eye opening – for clinical sponsors. By examining study factors known to be leading indicators of future clinical supply challenges, sponsors can take a proactive approach to clinical supplies, build realistic timelines and better forecast demand.